Analyzing process of evolution and adaptation through acquiring new mutations

FHS
July 29, 2023
4:05 am

The influenza (flu) virus is constantly undergoing a process of evolution and adaptation through acquiring new mutations.

Roivant recently sold one spinout for billions. Is Priovant next?

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 20, 2024

Pharmanovia signs licensing agreement for catumaxomab

The agreement enhances the oncology portfolio of Pharmanovia. Credit: Gorodenkoff/Shutterstock. Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialise catumaxomab, a new trifunctional

November 20, 2024

With younger women getting breast cancer, national panel lowers mammogram screening age to 40

A national advisory panel significantly lowered the age recommendations for screening mammography on Tuesday, saying that all women should start breast cancer screening at age

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.